However, TH588-induced anti-tumour effects may also be MTH1-dependent8, creating an apparent paradox in the literature on the role of MTH1 as valid target for therapy, and the use of its inhibitors in cancer treatment15–19 as reviewed elsewhere14. This evidence concerns the gene NUDT1 and neoplasm.